Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2007.03553.x/fullpdf
Reference86 articles.
1. Review article: infliximab therapy for inflammatory bowel disease-seven years on;Rutgeerts;Aliment Pharmacol Ther,2006
2. Review article: altering the natural history of Crohn’s disease - evidence for and against current therapies;Vermeire;Aliment Pharmacol Ther,2007
3. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal; surgery;Cosnes;Gut,2005
4. Maintenance of infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002
5. Infliximab maintenance therapy for fistulizing Crohn’s disease;Sands;N Engl J Med,2004
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment of primary nasal tuberculosis with anti-tumor necrosis factor immunotherapy: A case report;World Journal of Clinical Cases;2024-06-16
2. Screening practices, efficacy, safety and adherence to biologic therapies in a South African tertiary hospital;Frontiers in Musculoskeletal Disorders;2023-12-13
3. Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report;Journal of Ophthalmic Inflammation and Infection;2023-11-28
4. Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting;Intestinal Research;2023-07-31
5. Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations;Journal of Gastroenterology and Hepatology;2023-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3